ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $7,000 | +600.0% | 435 | +559.1% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 66 | -40.0% | 0.00% | – |
Q1 2022 | $2,000 | -50.0% | 110 | -41.8% | 0.00% | – |
Q4 2021 | $4,000 | +100.0% | 189 | +33.1% | 0.00% | – |
Q3 2021 | $2,000 | -85.7% | 142 | -74.6% | 0.00% | -100.0% |
Q2 2021 | $14,000 | +366.7% | 560 | +321.1% | 0.00% | – |
Q1 2021 | $3,000 | -50.0% | 133 | +25.5% | 0.00% | -100.0% |
Q4 2020 | $6,000 | +200.0% | 106 | +158.5% | 0.00% | – |
Q3 2020 | $2,000 | -95.1% | 41 | -95.8% | 0.00% | -100.0% |
Q1 2020 | $41,000 | -14.6% | 968 | -15.8% | 0.01% | +16.7% |
Q4 2019 | $48,000 | +41.2% | 1,149 | +18.7% | 0.01% | +20.0% |
Q3 2019 | $34,000 | +36.0% | 968 | 0.0% | 0.01% | +25.0% |
Q2 2019 | $25,000 | -62.7% | 968 | -58.7% | 0.00% | -88.2% |
Q4 2016 | $67,000 | -17.3% | 2,345 | -9.1% | 0.03% | -35.8% |
Q3 2016 | $81,000 | +1057.1% | 2,581 | +1022.2% | 0.05% | +960.0% |
Q2 2016 | $7,000 | +16.7% | 230 | +28.5% | 0.01% | +25.0% |
Q4 2015 | $6,000 | – | 179 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |